Clinical Sciences

Biotech spinout Resolution Therapeutics has announced it has raised £63.5 million in a series B financing round led by healthcare investor Syncona Ltd.

Data scientists and clinical researchers will use brain scans from the entire Scottish population to build a software tool that they hope will be able to predict a person’s risk of dementia.

A clinical trial follow-up featuring patients with end-stage liver cirrhosis shows increased survival rates and fewer liver transplants in those treated with macrophage cell therapy.

A tool developed at the University of Edinburgh has been shown to detect signs of motor neuron disease (MND) in brain tissue earlier than currently used tests.

Our capacity to diagnose and treat endometriosis lags behind that of other chronic conditions that similarly blight lives. But machine learning could change that, says consultant gynaecologist, Professor Andrew Horne, Director of the University of Edinburgh’s Centre for Reproductive Health.

The UK Government’s Director of the Office for Life Sciences (OLS) visited Edinburgh BioQuarter this week to understand how the health innovation district is contributing to health care advances globally.

The most extensive clinical study into liver cirrhosis ever conducted worldwide has been announced by Newcastle University, the University of Edinburgh and research-driven global biopharmaceutical company, Boehringer Ingelheim.